Cargando…

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study

PURPOSE: To investigate the temporal interrelationship between depression severity, cognitive symptoms, and functioning in patients with major depressive disorder (MDD) in the PERFORM study (NCT01427439). PATIENTS AND METHODS: PERFORM was a 2-year, multicenter, prospective, noninterventional cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haro, Josep Maria, Hammer-Helmich, Lene, Saragoussi, Delphine, Ettrup, Anders, Larsen, Klaus Groes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698581/ https://www.ncbi.nlm.nih.gov/pubmed/31616147 http://dx.doi.org/10.2147/NDT.S206825

Ejemplares similares

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
por: Saragoussi, Delphine, et al.
Publicado: (2018)

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
por: Hammer-Helmich, Lene, et al.
Publicado: (2018)

Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study
por: Haro, Josep Maria, et al.
Publicado: (2018)

Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J
por: Sumiyoshi, Tomiki, et al.
Publicado: (2021)

Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study
por: Wang, Gang, et al.
Publicado: (2020)

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi, Delphine, et al.
Publicado: (2017)

A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
por: Baune, Bernhard T, et al.
Publicado: (2017)

Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study
por: Chokka, Pratap, et al.
Publicado: (2021)

Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
por: Mattingly, Gregory W., et al.
Publicado: (2022)

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder
por: Lam, Raymond W, et al.
Publicado: (2018)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune, Bernhard T, et al.
Publicado: (2021)

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
por: Novick, Diego, et al.
Publicado: (2013)

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
por: Dannehl, Katharina, et al.
Publicado: (2014)

The effect of depressive symptoms on cognition in patients with fibromyalgia
por: Gelonch, Olga, et al.
Publicado: (2018)

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China
por: Wang, Gang, et al.
Publicado: (2019)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
por: Novick, Diego, et al.
Publicado: (2016)

Symptom severity of depressive symptoms impacts on social cognition performance in current but not remitted major depressive disorder
por: Air, Tracy, et al.
Publicado: (2015)

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
por: Santos García, Diego, et al.
Publicado: (2022)

Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East
por: Hong, Jihyung, et al.
Publicado: (2017)

Comparison of self-rating of cognition and depression in patients with major depressive disorder
por: Berra, Kishen, et al.
Publicado: (2020)

An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study
por: Ebert, Bjarke, et al.
Publicado: (2017)

Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia
por: Mauriño, Jorge, et al.
Publicado: (2011)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
por: Papalexi, Eugenia, et al.
Publicado: (2022)

Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
por: Wang, Gang, et al.
Publicado: (2022)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
por: Vieta, Eduard, et al.
Publicado: (2019)

Cognitive Behavioral Performance of Untreated Depressed Patients with Mild Depressive Symptoms
por: Li, Mi, et al.
Publicado: (2016)

The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder
por: Huang, Chun-Jen, et al.
Publicado: (2019)

Citalopram and metacognitive therapy for depressive symptoms and cognitive emotion regulation in patients with major depressive disorder: A randomized controlled trial
por: Kheirabadi, Gholam Reza, et al.
Publicado: (2020)

Linked patterns of symptoms and cognition with brain controllability in major depressive disorder
por: Li, Q., et al.
Publicado: (2023)

Patient Perspective of Cognitive Symptoms in Major Depressive Disorder: Retrospective Database and Prospective Survey Analyses
por: Chiauzzi, Emil, et al.
Publicado: (2019)

Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
por: Di Nicola, Marco, et al.
Publicado: (2023)

Direct and indirect influences of childhood abuse on depression symptoms in patients with major depressive disorder
por: Hayashi, Yumi, et al.
Publicado: (2015)

Clinical Depression, Depressive Symptoms, and Depressed Cognition in Caregiving Grandmothers
por: Burant, Christopher, et al.
Publicado: (2020)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
por: Novick, Diego, et al.
Publicado: (2017)

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?
por: Hong, Jihyung, et al.
Publicado: (2015)

Results and validation of an index to measure health state of patients with depression in automated healthcare databases
por: Lamy, François-Xavier, et al.
Publicado: (2019)

The association between persistent cognitive difficulties and depression and functional outcomes in people with major depressive disorder
por: Matcham, F., et al.
Publicado: (2023)

The Impact of Residual Symptoms in Major Depression
por: Israel, Joshua A.
Publicado: (2010)

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_njasocnefudafda3i5t6b9klpu